21 May 2022 : Clinical Research
Curative Analysis of Patients with Hepatocellular Carcinoma Using Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation
Yifan Li1AE, Diwen Zhu1BCD, Weixin Ren1AE*, Junpeng Gu1BCD, Weizheng Ji1BCD, Haixiao Zhang1BCD, Yingjun Bao1BCD, Gengfei Cao1BCD, Asihaer Hasimu1BCDDOI: 10.12659/MSM.936246
Med Sci Monit 2022; 28:e936246
Supplementary Table 1 Comparison between groups before and after data imputation.
| Variables | After (n=142) | Before (n=142) | Statistics | P |
|---|---|---|---|---|
| AFP, ng/ml, M (Q, Q) | 14.35 (4.40, 235.00) | 14.35 (4.55, 203.80) | Z=0.365 | 0.715 |
| Tbil, μmol/L, M (Q, Q) | 16.50 (10.90, 20.80) | 16.50 (10.90, 20.80) | Z=−0.045 | 0.964 |
| Albumin, U/L, Mean±SD | 38.55±6.07 | 38.47±6.03 | t=0.10 | 0.919 |
| ALT U/L, M (Q, Q) | 25.36 (18.20, 39.69) | 26.02 (18.30, 39.69) | Z=0.102 | 0.918 |
| AST U/L, M (Q, Q) | 30.60 (22.85, 42.50) | 30.50 (22.85, 40.90) | Z=−0.088 | 0.930 |
| LDH, U/L, Mean±SD | 189.82±41.75 | 189.80±43.16 | t=0.00 | 0.996 |
| ALP, U/L, M (Q, Q) | 91.50 (70.00, 126.00) | 92.00 (71.00, 126.00) | Z=0.164 | 0.870 |
| AFP – alpha-fetoprotein; Tbil – total bilirubin; ALT – alanine transaminase; AST – aspartate transaminase; LDH – lactic dehydrogenase; ALP – alkaline phosphatase. | ||||